TFG Advisers’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$361K Buy
3,259
+18
+0.6% +$1.92K 0.12% 161
2025
Q1
$363K Buy
3,241
+19
+0.6% +$1.96K 0.13% 154
2024
Q4
$298K Buy
3,222
+49
+2% +$4.41K 0.11% 169
2024
Q3
$266K Sell
3,173
-11
-0.3% -$839 0.1% 180
2024
Q2
$218K Buy
3,184
+26
+0.8% +$1.74K 0.08% 187
2024
Q1
$231K Sell
3,158
-54
-2% -$4.15K 0.09% 188
2023
Q4
$260K Buy
3,212
+23
+0.7% +$1.79K 0.11% 166
2023
Q3
$239K Sell
3,189
-420
-12% -$32.3K 0.11% 170
2023
Q2
$278K Sell
3,609
-376
-9% -$30K 0.13% 161
2023
Q1
$331K Sell
3,985
-331
-8% -$27.4K 0.16% 137
2022
Q4
$371K Buy
4,316
+107
+3% +$8.47K 0.19% 125
2022
Q3
$260K Buy
4,209
+73
+2% +$4.6K 0.15% 152
2022
Q2
$256K Sell
4,136
-27
-0.6% -$1.67K 0.14% 158
2022
Q1
$247K Buy
4,163
+17
+0.4% +$1.09K 0.11% 181
2021
Q4
$301K Sell
4,146
-415
-9% -$28.6K 0.13% 159
2021
Q3
$319K Sell
4,561
-690
-13% -$48.5K 0.15% 146
2021
Q2
$362K Sell
5,251
-1,167
-18% -$77.9K 0.17% 136
2021
Q1
$415K Sell
6,418
-41
-0.6% -$2.64K 0.21% 112
2020
Q4
$376K Buy
6,459
+206
+3% +$12.4K 0.2% 125
2020
Q3
$395K Buy
6,253
+150
+2% +$10.4K 0.23% 106
2020
Q2
$469K Buy
6,103
+313
+5% +$24K 0.3% 93
2020
Q1
$432K Sell
5,790
-578
-9% -$39.9K 0.34% 90
2019
Q4
$413K Buy
6,368
+8
+0.1% +$521 0.23% 103
2019
Q3
$403K Buy
6,360
+55
+0.9% +$3.6K 0.27% 103
2019
Q2
$426K Buy
6,305
+250
+4% +$16.4K 0.29% 100
2019
Q1
$393K Sell
6,055
-65
-1% -$4.32K 0.28% 103
2018
Q4
$382K Buy
+6,120
New +$428K 0.32% 98

Other funds holding GILD

TFG Advisers's GILD Position: Q2 2025 in Review

TFG Advisers increased its Gilead Sciences (GILD) stake by 0.56% in Q2 2025, buying an estimated $1.92K and bringing the position to 3,259 shares worth $361K. The position accounts for 0.12% of the portfolio, ranked #161.

TFG Advisers first reported a position in GILD in Q4 2018 and has held it in 27 quarters since. The position peaked at $469K in Q2 2020. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • TFG Advisers held 3,259 shares of Gilead Sciences worth $361K as of Q2 2025.
  • TFG Advisers bought 18 Gilead Sciences shares in Q2 2025, an estimated $1.92K.
  • Gilead Sciences made up 0.12% of TFG Advisers's portfolio in Q2 2025, its #161 holding.
  • TFG Advisers first reported a position in Gilead Sciences in Q4 2018 and has held it in 27 quarters since.
  • TFG Advisers's Gilead Sciences position peaked at $469K in Q2 2020.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on TFG Advisers's 13F filing for Q2 2025, filed 21 Jul 2025.